Skip to main content
Clinical Trials/NCT02941900
NCT02941900CompletedNot Applicable

PERSONALIZED GENOMIC TESTING FOR MELANOMA: MAXIMIZING COMPREHENSION AND HEALTH OUTCOMES IN SKIN CANCER PATIENTS

Memorial Sloan Kettering Cancer Center1 site in 1 country53 target enrollmentStarted: August 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
53
Locations
1
Primary Endpoint
number of patients interested in MC1R testing

Study Overview

Brief Summary

The purpose of this study is to learn whether the patient might be interested in skin cancer genetic testing, and if so, what kinds of thoughts, feelings, and behaviors might result from this testing. Testing for skin cancer risk based on the MC1R gene is not currently used in clinical practice; it will be offered in this study for research purposes only.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • 18 years of age or older
  • English fluent as we do not have the resources to translate all the materials including the website and risk feedback materials into other languages
  • Prior history of stage 0, I or II NMSC as per EMR or clinical judgment

Exclusion Criteria

  • Inability to provide meaningful informed consent due to cognitive or psychiatric disability as determined by the judgement of the consenting professional or clinician

Outcomes

Primary Outcomes

number of patients interested in MC1R testing

Time Frame: 1 year

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Interest and Impact of Skin Cancer Genetic... | Clinical Trial